Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
The present invention is concerned with a compound of formula (Ap) or a pharmaceutically acceptable salt thereof,wherein P1 represents a hydroxy protecting group and P3 represents an amino protecting group. The present invention is also related to a process for preparing a compound of formula (I) or any pharmaceutically acceptable salt thereof, via a novel intermediate compound (Ap).